Argyria associated with colloidal silver supplementation

International Journal of Dermatology

Volumn 42, Issue 7, 2003, Pages 549-

  McKenna, Jeffrey K ^a   Hull, Christopher M ^a   Zone, John J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; GLIBENCLAMIDE; METFORMIN; SILVER CHLORIDE; SILVERZONE;

AGED; ANAMNESIS; ARGYRIA; CASE REPORT; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EXPOSURE; FINGER NAIL; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; NAIL COLOR DEFECT; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION;

AGED; ARGYRIA; COLLOIDS; DIABETES MELLITUS; DIETARY SUPPLEMENTS; HUMANS; MALE; NAIL DISEASES; SILVER;

EID: 0038268811     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01899.x     Document Type: Conference Paper

References (5)

1. Gulranson SH, Hud JA Jr, Hansen RC. Argyria following the use of dietary supplements containing colloidal silver protein. Cutis 2000; 66: 373-374.
2. Padlewska K, Schwartz R. Argyria. In: Elston D, James W, eds. eMedicine: Dermatology and Online Medical Reference.
3. 3. J Dermatol 1994; 21: 50-53.
4. Prescott RJ, Wells S. Systemic argyria. J Clin Pathol 1994; 47: 556-557.
5. Fung MC, Bowen DL. Silver products for medical indications: Risk-benefit assessment. J Toxicol Clin Toxicol 1990;34:119-126.